type 2 diabetes Flashcards

1
Q

pathophysiology of type 2 diabetes

A

COMBINATION of insulin resistance (the unique characteristic) and beta cell failure that result in hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is the resultant chronic hyperglycaemia initially managed? can it be reversable?

A

diet/ weigh loss yes it can

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

is diet sufficient management long term?

A

no, glu lowering needed, including insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what diseases may trigger diabetes presentation?

A

pancreatic damage or other endocrine disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

observations on the prevalence of t2d

A

varies enormously across ehtnic gorups
greatest in ethnic groups that move form rural to urban lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the changes observed in the epidimeology of t2 diabetes?

A

prevalence incr in general from past

diab occuring and being diagnosed younger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how many stages are there in the t2d spectrum and what are the 3 factors that are different in each ?

A

3 stages: 1) normal, 2) intermediate 3) type 2 diabetes
and the three factors are: 1) fasting glucose levels 2) imparied glu tolerance 3) hba1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

range values for fasting glu, imparied glu tolerance and hba1c for the 3 stages of disease

A

fasting glu: 6 <intermid stage <7 mmol/L

(when equal to 6 and 7 included in the other respective categories)

impaired glu tol: 7.7</=mid<11 mmol/L

hbaic: 42</= mid< 48

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

at which disease stage is insulin prod the highest/ peaks? What is the overall pattern

A

intermediate: peak (low before and drops even lower than before- can even reach 0 during t2d)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the pattern of insulin resistance level?

A

zero at normal , slowly increases in intermediate, plateaus at t2d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the clinical term for the intermediate stage

A

pre-diabetic hyperglycaemia or pre-diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the term for fasting glucose levels at the intermediate stage?

A

Impaired fasting glycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the term for impaired glu tolerance at intermediate stage?

A

impaired glu tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when can you diagnose diabetes?

A

diabetic random glu and symptoms of diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(see slide 12) why do t2d patients present at earlier stages of b cell function loss compared to t1d patients?

A

Because even at 50% loss (in contrast to 80% loss for average presentation in type 1) you are resistant so the 50% that are working are not enough bc theres resistance while theres no resist for type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is a clinical scenario of diabetes where this point of the resistance acting as a catalyst for your presentation even with not that huge losses of b cells?

A

pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is this phenomenon of not enough insulin production to overcome insulin resistance called?

A

RELATIVE insulin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

why does the hyperglycemia encountered in t2d usually does not cause ketosis?

A

bc of RELATIVE insulin def. bc there IS insulin to inhibit ketone body production in liver, its just that the target cells in body are resistant to it but it EXISTS in circulation so can still inhibit ketone bodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

when can type 2 diab get ketosis?

A

after theyve had infection in pancreas, diabetes for very long and pancr is shutting down- no glu prod cytotoxic or lipotoxic (from too much lip not being conv to ketone bod bc too much insulin perhaps?) pancr (10-20 yrs),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

is it better to stop insulin in someone with long term type 2 (maybe u see theyre on low dose and want to spare them the lifestyle burdain) or better to keep?

A

ITS CRUCIAL CRUCIAL to keep the isnulin treatment bc the longer into the disease the higher risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

4 categories of pathophysiology of type 2

A

1) genes
2) intrauterine environment/ adult environment
3) insulin resistance and insulin secretion defects
4) fatty acids (role in pathogenesis AND complications)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

in what ways is type 2 diabetes variable?

A

1) heterogenous (means theres different causes for it:)
2) people develop it at variable BMI, ages and progress differently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what risks does gestational diabetes have?

A

incr. risk of mother and child having normal diabetes
mother: pancreas already has some resistance so …
child: either epigenetic changes or bc of following a certain lifestyle of mother/ family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is a hyperglycemic clamp?

A

when they give you a specific amount of glucose IV for a continuous time frame to measure your body’s responding insulin production. (basically used to measure b cell function)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

difference between standard glu tolerance test and hyperglycemic clamp?

A

GTT measures GLUCOSE after EATING usualllly a sugary drink after having FASTED, aim is to see if body can lower glu levels, used to DIAGNOSE diabetes, more natural repsonce observation. clamp is more artificial way, not used for diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is observed in insulin production after givinf the iv glu challeneg to t2d vs normal?

A

spike in insulin prod immediately after glu challenge given in normal vs minimal insul prod in t2d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

2 basic mechanisms of low insulin causing increased FPG (fasting plasma glucose levels)? (and the official terms)

A

1) glucose cant enter target cells eg peripheral muscles (impaired-insulin mediated glucose disposal)

2) gluconeogenesis not inhibited by insulin anymore, glucagon is allowed to act on liver : hepatic glucose production is increased (excessive glucagon-mediated glucose output)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what are two ways/ terms to describe glucose not being able to enter tafrget cells due to low/ resistance to insulin?

A

impaired insulin- mediated glucose disposal

reduced metabolic clearance rate of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what event does Cori cycling refer to?

A

the excessive amounts of glucose in blood converted to lactate which then returns to the liver to be metabolized back to glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what event could explain early morning increase in FPG in the progression to T2DM

A

cori cycling from previous nights meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

2 more mechanisms of Further increasing FGP in diabetes.

A

Inadequate insulin action also causes an increased flux of substrates – glycerol and free fatty acids – to the liver, resulting in increased gluconeogenesis.

Inappropriate glucagon secretion induces continued glucose production by stimulating glycogenolysis (release of glucose from glycogen, its stored form) (in addition to already mentioned gluconeogenesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

ABOVE WHAT FPG levels is HGP more evident (in mg/dl)

A

> 140

33
Q

American Diabetes Association’s diagnostic criterion for FPG?

A

> /= 126 mg/dl

34
Q

look at ipad for relationship between insulin resistance and secretion

A
35
Q

3 other lipid/ adipocyte related consequences of low insulin

A

insulin normally incr the conversion of trig to gly and nefa so they can enter adipocytes. now not conv, stay in blood

also insulin stimulates transporter allowing glu to enter adipocytes

also promotes recombination of gly and nefa in adipocyte so they can leave again

36
Q

does glucagon have an effect on muscle cell glucose transporters (that llow glu into cell?)

A

yes, inhibits them

37
Q

what is monogenic vs polygenic diabetes?

A

monogenic: MODY (maturity onset diabetes of the young) - single gene mutation causes it, ur born with it

polygenic: you have polymorphisms that incr risk, may develop later DEPENDING on other factors

38
Q

is the proportion of environmental / genetic factors influencing t2d onset relatively fixed for df people?

A

no, very variable may have low gen risk and low env: low general
or very low env and very high genetic

39
Q

what is the usual cause of a lean person having t2d?

A

problem with pancreas b cells insulin production

40
Q

how are GWAS done for diabetes related nucleotide changes?

A

u get people with t2d and controls and look at Nucleotide changes present in type 2 diabetes group but not controls

41
Q

average percentage risk of diabetes with one single nucleotide polymorphism

A

1.2%

42
Q

average absolute risk of diabetes with 40 nucleotide polymorphisms

A

11.2% (prevalence)

43
Q

what % of t2diabetics are obese?

A

80%

44
Q

what components/ mechanism of obesity make it major risk factor for t2d?

A

Fatty acids and adipocytokines important
Central (subcutaneous) vs visceral )(problem) obesity

45
Q

what are some other factoras that have been correlated/ associated with t2d?

A

1) Perturbations (αναστατώσεις) in gut microbiota

2) fermentation of Bacterial lipopolysaccharides to short chain FA,

3) bacterial modulation of bile acids

4) Inflammation, signaling metabolic pathways

5) Intra-uterine growth retardation

46
Q

what is did hales et al 1991 show abt intra uterine growth retardation and t2 diabetes

A

Weight at age 1 year <8.16kg, 22% had type 2 diabetes or IGT (impaired glucose tolerance)
Weight age 1 year >12.25 kg, 6% had type 2 diabetes or IGT

(meaning, more underweight children at 1yr get t2d)

47
Q

typical t2d symptoms

A

Hyperglycaemia
Overweight
Dyslipidaemia (can have)
osmotic symptoms (fewer)
With complications
Insulin resistance
Later insulin deficiency

infections,

48
Q

what are the complicaitons associated with t2d and at what stage of disease do thwy happen

A

later in disease more long term

renal failure (diabetic nephropathy)
nerve disease
arteriosclerosis

stroke (HYPEROSMOLAR BLOOD- VISCOUS- BLOOD CLOTS- STORKE)
eye disease ( diabetic retinopathy, GLAUCOMA, CATARACT)
diabetic foot (eventually u feel numb and stuff in your feet)
heart damage
stroke

49
Q

acute t2d presentaiton

A

hyperosmolar hyperglycaemic state

50
Q

chronic t2d presentaiton

A

(complications linked) ischaemic heart disease, retinopathy

51
Q

firs tline t2d diagnosis

A

1x HBA1C> 48 AND symptoms OR
2X HBAC> 48 IF NO SYMPOTMS

52
Q

WHAT COMplication does hyperosmolar hyperglucemic state commonly present wotih?

A

renal failure

53
Q

why is there not ketogenesis and lipolysis in hyperglycaemic hyperosmolar patients ( clearly there have insulin problem)?

A

because even though insulin not enough for supression of hyperglyc, it IS ENOUGH TO SUPRESS ketogenesis (->acidosis) and lipolysis

54
Q

what is a common history of presenting complaint for hyperosmolar hyperglycaemic state

A

some identifyable percipitating event such as infection or MI

55
Q

what are two common areas of management in t1 and t2 d

A
  • giving insulin (t1 always: basal-bolus treatment- t2d: maybe give later in disease)
    -structured education
56
Q

unique type 1 and 2management strategies

A

t1d:
technology
self monitoring glu

t2d
diet
oral medication

57
Q

things to do in t2d consultation

A

glucose monitor (hbac1)
medications check
weight assessment

blood pressure
dyslipidaemia (cholesterol profile)
complications check

58
Q

dietary recommendations and education 6 pricnciples

A

total calories control
reduce calories as fat
reduce calories as refined carbohydrate
decr sodium

increase calories as complex carbohydrate
increase soluble fibre

59
Q

what doe metformin do?

A

1) reduce hepatic glucose production -
2) improve insulin sensitivity
(also increases peripheral glucose disposal)

60
Q

what do thiozolidinediones do (pioglitazone) ? what is their medical name?

A

2) improve insulin sensitivity (mainly peripheral )

-Peroxisome proliferator-actived receptor agonists PPAR-γ

61
Q

advantages/ disadvantages of pioglitazone and what type of

A

disadv
Adipocyte differentiation modified, weight gain but peripheral not central

Side effects of older types hepatitis, heart failure

may cause wight incr
adv:
Improvement in glycaemia and lipids

62
Q

what to sulphonylureas do? (DPP4 inhibitors GLP-1 Agonists) and how specifically?

A

boost insulin secretion.

-normally glucose gets in b cell by glut 2, converted to atp, blocks K channel, K stays in cell, stimulates ca channel, ca flows in, stimulates insulin secretion

  • bc theres no glucose coming into cell, atp cant vlock k channel so this drUg does this instead (plays role of ATP)
63
Q

what does Alpha glucosidase inhibitor
SGLT-2 inhibitor do?

A

Inhibit carbohydrate gut absorption
Inhibit renal glucose resorption

64
Q

what problems does weigh loss help?

A

all the problems

65
Q

what category of srugs is metformin under

A

biguanide

66
Q

when is metformin given

A

when first line/ dietary hasnt worked

67
Q

metformin side effects and when is it contraindicated

A

GI side effects
Contraindicated in severe liver, severe cardiac or moderate renal failure

68
Q

what is a common side effect of glucose lowering therapies? how is emtformin bit diff?

A

wight gain, metformin: can weigh loss

69
Q

WHAT IS GLP-1 (glucagon like peptide -1)

A

Gut hormone
Secreted in response to nutrients in gut
Transcription product of the gene coding for proglucagon (precursor of glucagon) , mostly from L-cell

70
Q

what does glp-1 do molecularly and clinically ?

A

Stimulates insulin, suppresses glucagon

Used in treatment of diabetes mellitus

liraglutide, semaglutide
↑ satiety (feeling of ‘fullness’). (weight loss)
injectable daily or weekly

71
Q

why does glp1 have short half life?

A

due to rapid degradation from enzyme dipeptidyl peptidase-4 (DPP4 inhibitor)

72
Q

what is the incretin effect and why do we care

A

The relative increase in insulin in response to oral glucose relative to intravenous glucose is known as the incretin effect. Relevant for treatment T2dm.

73
Q

examples of GLP-1 agonists

A

Liraglutide, Semaglutide

74
Q

DPP-4 inhibitor (gliptin) and what does it do molecularly and clinically?

A

Increase half life of exogenous GLP-1
Increase [GLP-1]
Decrease [glucagon]
Decrease [glucose]
Neutral on weight

75
Q

what do SGLT2 INHIBITORS DO molecularly and clinically

A

inInhibits Na-Glu transporter, increases glycosuria
HbA1c lower
32% lower all cause mortality
35% lower risk heart failure
Improve CKD

76
Q

SGLT2 INHIBITORS examples of drugs

A

Empagliflozin, dapagliflozin, canaglifloz

77
Q

dif between remission and cure

A

n summary, “treatment” involves the active management and care provided to address a medical condition, while “remission” describes the state in which the signs and symptoms of the condition have significantly improved or disappeared.

78
Q

APPROAches to achieve remission of t2d

A

Gastric bypass surgery has the potential to induce remission of type 2 diabetes

DIRECT Study / DROPLET study: very low-calorie diet (800 kcal/day) for 3-6 months has the potential to induce remission, which appears to be sustained at 2 years

79
Q

other aspects of t2d management? and how

A

Blood Pressure management
Hypertension very common in T2DM
Clear benefits for reduction esp with use of ACE-inhibitors

Lipid management
Total cholesterol raised
Triglycerides raised
HDL cholesterol reduced
Clear benefit to lipid-lowering therapy